Skip to content

An Evaluation of Low Level Laser Therapy Versus Mirror Therapy for Managing Post-Stroke Pain Syndromes

Effectiveness of Low Level Laser Therapy against Mirror Therapy in Post-stroke Complex Regional Pain Syndrome type 1 stage 1 - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086943
Enrollment
44
Registered
2025-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G998- Other specified disorders of nervous system in diseases classified elsewhere

Interventions

Intervention1: Educational program, Kinesiotherapy, Low Level Laser Therapy (LLLT): Participants will receive Low-Level Laser Therapy (LLLT) in group 1 with BTL-5000 series v300, SN 038-B-02947, accor

Sponsors

Nil Ratan Sircar Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (i) First time stroke patients with diagnosed post stroke CRPS-1of stage 1in hemiparetic upper limb according to Budapest criteria12. (ii) Stable neurologic status. (iii) Sufficient cognitive function to learn. (iv) Sufficient communicative ability to engage with the therapists/caregiver. (iii) Age between 45 years to 65years.

Exclusion criteria

Exclusion criteria: (i) Prior disorder or surgery impairing the movement of the affected upper limb. (ii) Duration of stroke is more than 6 months. (iii) Upper limb spasticity score greater than 3 in Modified Ashworth Scale. (iv) Presence of contractures in the affected upper limb. (v) Presence of Hemi-neglect. (vi) Complete flaccidity of the affected upper limb. (vii) Patients with diagnosed Brachial plexus injury. (viii) Contraindication for prescribing therapeutic exercises

Design outcomes

Primary

MeasureTime frame
To assess the effectiveness of LLLT vs. MT in post-stroke CRPS-1 type 1Timepoint: At the baseline (visit 1), at 4 weeks (visit 2), 8 weeks (visit 3) and at the end of the study or 12 weeks (visit 4).

Secondary

MeasureTime frame
(i) To Assess Improvement in pain both during active & passive movements. (ii) To find out Sensory-motor improvement. (iii) To Assess Improvement in ADL. Timepoint: at the baseline (visit 1), at 4 weeks (visit 2), 8 weeks (visit 3) & at the end of the study or 12 weeks (visit 4).

Countries

India

Contacts

Public ContactDr Saumen Kumar De

NRS Medical College and Hospital

drsaumen16@gmail.com9433124596

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 18, 2026